References
- National Institute for Health and Care Excellence. Menopause:
diagnosis and management; 2021. Accessed: 2021-07-11.
https://www.nice.org.uk/guidance/ng23
- Pentti K, Honkanen R, Tuppurainen MT, Sandini L, Kroger H, Saarikoski
S. Hormone replacement therapy and mortality in 52 to 70 year old
women: the Kuopio Osteoporosis Risk Factor and Prevention Study.
European journal of endocrinology. 2006;154(1):101–107.
- Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer
MJ. A prospective, observational study of postmenopausal hormone
therapy and primary prevention of cardiovascular disease. Annals of
internal medicine. 2000;133(12):933– 941.
- Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, et al.
Hormone therapy to prevent disease and prolong life in postmenopausal
women. Annals of internal medicine. 1992;117(12):1016–1037.
- Collaborative Group on Hormonal Factors in Breast Cancer. Type and
timing of menopausal hormone therapy and breast cancer risk:
individual participant meta-analysis of the worldwide epidemiological
evidence. The Lancet. 2019 Sep 28;394(10204):1159-68.
- Grady D, Gebretsadik T, Kerlikowske K, Ernster V, Petitti D. Hormone
replacement therapy and endometrial cancer risk: a meta-analysis.
Obstetrics & Gynecology. 1995;85(2):304–313.
- Collaborators MWS, Beral V, Bull D, Reeves G. Endometrial cancer and
hormone replacement therapy in the Million Women Study. The Lancet.
2005;365:1543–51.
- Collaborators MWS, et al. Ovarian cancer and hormone replacement
therapy in the Million Women Study. The Lancet.
2007;369(9574):1703–1710.
- Collaborators MWS, et al. Breast cancer and hormone replacement
therapy in the Million Women Study. The Lancet.
2003;362(9382):419–27.
- Hodis HN, Mack WJ, Azen SP, Lobo RA, Shoupe D, Mahrer PR, et al.
Hormone therapy and the progression of coronary-artery atherosclerosis
in postmenopausal women. New England Journal of Medicine.
2003;349(6):535–545.
- Persson I, Yuen J, Bergkvist L, Schairer C. Cancer incidence and
mortality in women receiving estrogen and estrogen-progestin
replacement therapy—long-term follow-up of a Swedish cohort.
International journal of cancer. 1996;67(3):327–332.
- Beral V, Peto R, Pirie K, Reeves G. Menopausal hormone therapy and
20-year breast cancer mortality. The Lancet. 2019;394(10204):1139.
- Schuetz F, Diel IJ, Pueschel M, et al. Reduced incidence of distant
metastases and lower mortality in 1072 patients with breast cancer
with a history of hormone replacement therapy. American Journal of
Obstetrics & Gynecology. 2007;196(4):342.e1– 342.e9.
- Folsom AR, Mink PJ, Sellers TA, Hong CP, Zheng W, Potter JD. Hormonal
replacement therapy and morbidity and mortality in a prospective study
of postmenopausal women. American Journal of Public Health.
1995;85(8):1128–1132.
- Ettinger B, Friedman GD, Bush T, Quesenberry Jr CP. Reduced mortality
associated with long-term postmenopausal estrogen therapy. Obstetrics
& Gynecology. 1996;87(1):6–12.
- Hunt K, Vessey M, MCPHERSON K, Coleman M. Long-term surveillance of
mortality and cancer incidence in women receiving hormone replacement
therapy. BJOG: An International Journal of Obstetrics & Gynaecology.
1987;94(7):620–635.
- Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson JE, Joffe M,
et al. Postmenopausal hormone therapy and mortality. New England
Journal of Medicine. 1997;336(25):1769–1776.
- Salpeter SR, Cheng J, Thabane L, Buckley NS, Salpeter EE. Bayesian
meta-analysis of hormone therapy and mortality in younger
postmenopausal women. The American journal of medicine.
2009;122(11):1016–1022.
- Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix
AZ, et al. Menopausal hormone therapy and long-term all-cause and
cause-specific mortality: the Women’s Health Initiative randomized
trials. Jama. 2017;318(10):927–938.
- Benkhadra K, Mohammed K, Al Nofal A, Carranza Leon BG, Alahdab F,
Faubion S, et al. Menopausal hormone therapy and mortality: a
systematic review and metaanalysis. The Journal of Clinical
Endocrinology & Metabolism. 2015;100(11):4021– 4028.
- Holm M, Olsen A, Au Yeung S, Overvad K, Lidegaard Ø, Kroman N, et al.
Pattern of mortality after menopausal hormone therapy: long-term
follow up in a population-based cohort. BJOG: An International Journal
of Obstetrics & Gynaecology. 2019;126(1):55–63.
- Malek AM, Vladutiu CJ, Meyer ML, Cushman M, Newman R, Lisabeth LD, et
al. The association of age at menopause and all-cause and
cause-specific mortality by race, postmenopausal hormone use, and
smoking status. Preventive medicine reports. 2019;15:100955.
- Stram DO, Liu YO, Henderson KD, Sullivan-Halley J, Luo J, Saxena T, et
al. Agespecific effects of hormone therapy use on overall mortality
and ischemic heart disease mortality among women in the California
Teachers Study. Menopause (New York, NY). 2011;18(3):253.
- British Medical Association. Verification of death (VoD); 2020.
Accessed: 2021-09-10. https://www.bma.org.uk/media/2843/
bma-verification-of-death-vod-july-2020.pdf.
- Blak B, Thompson M, Dattani H, Bourke A. Generalisability of The
Health Improvement Network (THIN) database: demographics, chronic
disease prevalence and mortality rates. Journal of Innovation in
Health Informatics. 2011;19(4):251–255.
- IQVIA Medical Research Data. Data collection arrangements; 2017.
Accessed: 2020-07-28.
https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/the-health-improvement-network-thin-database/.
- Bradley SH, Lawrence NR, Carder P. Using primary care data for health
research in England–an overview. Future healthcare journal.
2018;5(3):207.
- The Health Foundation. Female sex hormones and their modulators; 2018.
Accessed: 2018-09-10. https://openprescribing.net/bnf/060401/.
- Big Health Actuarial Data Project.
http://www.bighealthactuarialdata.ac.uk/team.
- Springate DA, Kontopantelis E, Ashcroft DM, Olier I, Parisi R,
Chamapiwa E, et al. ClinicalCodes: an online clinical codes repository
to improve the validity and reproducibility of research using
electronic medical records. PloS one. 2014;9(6):e99825.
- Norman P, Darlington-Pollock F. The changing geography of deprivation
in Great Britain: exploiting small area census data, 1971 to 2011. In:
The Routledge Handbook of Census Resources, Methods and Applications.
Routledge; 2017. p. 404–420.
- Peng M, Chen G, Kaplan GG, Lix LM, Drummond N, Lucyk K, et al. Methods
of defining hypertension in electronic medical records: validation
against national survey data. Journal of Public Health.
2016;38(3):e392–e399.
- Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics
based on weighted residuals. Biometrika. 1994;81(3):515–26.
- Begun A, Kulinskaya E, MacGregor AJ. Risk-adjusted CUSUM control
charts for shared frailty survival models with application to hip
replacement outcomes: a study using the NJR dataset. BMC medical
research methodology. 2019;19(1):1–15.
- Marshall A, Altman DG, Holder RL. Comparison of imputation methods for
handling missing covariate data when fitting a Cox proportional
hazards model: a resampling study. BMC medical research methodology.
2010;10(1):1–10.
- Van Buuren S. Flexible imputation of missing data. CRC press; 2018.
- Rubin DB. Multiple imputation for survey nonresponse. New York: Wiley;
1987.
- Therneau T, Atkinson E. The concordance statistic. 2020.
- Gillam SJ, Siriwardena AN, Steel N. Pay-for-performance in the United
Kingdom: impact of the quality and outcomes framework—a systematic
review. The Annals of Family Medicine. 2012;10(5):461–468.
- Bromley S, Vries C, Farmer R. Utilisation of hormone replacement
therapy in the United Kingdom. BJOG: An International Journal of
Obstetrics & Gynaecology. 2004;111(4):369–76.
- Kontopantelis E, Stevens RJ, Helms PJ, Edwards. Spatial distribution
of clinical computer systems in primary care in England in 2016 and
implications for primary care electronic medical record databases: a
cross-sectional population study. BMJ open. 2018;8(2):e020738.
- Salpeter SR, Walsh JM, Greyber E, Ormiston TM, Salpeter EE. Mortality
associated with hormone replacement therapy in younger and older
women. Journal of general internal medicine. 2004;19(7):791–804.
- Drever F, Whitehead M. Mortality in regions and local authority
districts in the 1990s: exploring the relationship with deprivation.
Population trends. 1995;(82):19– 26.
- NICE. Menopause: diagnosis and management; 2019. Accessed: 2021-09-23.
https://www.nice.org.uk/guidance/ng23/chapter/Recommendations#long-term-benefits-and-risks-of-hormone-replacement-therapy.